Ledipasvir/sofosbuvir treatment of hepatitis C virus is associated with reduction in serum apolipoprotein levels.
about
Liver Transplantation: the Role of Metabolic Syndrome.Neglected but Important Role of Apolipoprotein E Exchange in Hepatitis C Virus Infection.Rapid Changes in Serum Lipid Profiles during Combination Therapy with Daclatasvir and Asunaprevir in Patients Infected with Hepatitis C Virus Genotype 1b.Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA Therapy
P2860
Ledipasvir/sofosbuvir treatment of hepatitis C virus is associated with reduction in serum apolipoprotein levels.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Ledipasvir/sofosbuvir treatmen ...... n serum apolipoprotein levels.
@en
type
label
Ledipasvir/sofosbuvir treatmen ...... n serum apolipoprotein levels.
@en
prefLabel
Ledipasvir/sofosbuvir treatmen ...... n serum apolipoprotein levels.
@en
P2093
P2860
P356
P1476
Ledipasvir/sofosbuvir treatmen ...... n serum apolipoprotein levels.
@en
P2093
D M Brainard
E Elsheikh
J G McHutchinson
M Stepanova
Z M Younossi
P2860
P304
P356
10.1111/JVH.12448
P577
2015-08-17T00:00:00Z